YS Biopharma Net Worth

YS Biopharma Net Worth Breakdown

  YSBPW
The net worth of YS Biopharma Co is the difference between its total assets and liabilities. YS Biopharma's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of YS Biopharma's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. YS Biopharma's net worth can be used as a measure of its financial health and stability which can help investors to decide if YS Biopharma is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in YS Biopharma Co stock.

YS Biopharma Net Worth Analysis

YS Biopharma's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including YS Biopharma's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of YS Biopharma's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform YS Biopharma's net worth analysis. One common approach is to calculate YS Biopharma's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares YS Biopharma's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing YS Biopharma's net worth. This approach calculates the present value of YS Biopharma's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of YS Biopharma's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate YS Biopharma's net worth. This involves comparing YS Biopharma's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into YS Biopharma's net worth relative to its peers.
To determine if YS Biopharma is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding YS Biopharma's net worth research are outlined below:
YS Biopharma is way too risky over 90 days horizon
YS Biopharma has some characteristics of a very speculative penny stock
YS Biopharma appears to be risky and price may revert if volatility continues
YS Biopharma has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 687.2 M. Net Loss for the year was (283.47 M) with profit before overhead, payroll, taxes, and interest of 0.
YS Biopharma generates negative cash flow from operations
YS Biopharma has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Short Interest in YS Biopharma Co., Ltd. Decreases By 45.0 percent - Defense World
YS Biopharma time-series forecasting models is one of many YS Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary YS Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

YS Biopharma Earnings per Share Projection vs Actual

Be your own money manager

Our tools can tell you how much better you can do entering a position in YS Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

How to buy YSBPW Stock?

The net worth of YS Biopharma Co is the difference between its total assets and liabilities. YS Biopharma's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of YS Biopharma's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. YS Biopharma's net worth can be used as a measure of its financial health and stability which can help investors to decide if YS Biopharma is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in YS Biopharma Co stock.

Already Invested in YS Biopharma Co?

The danger of trading YS Biopharma Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of YS Biopharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than YS Biopharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile YS Biopharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YSBPW Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in YS Biopharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for YSBPW Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YSBPW will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of YS Biopharma is measured differently than its book value, which is the value of YSBPW that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.